Market
Market Analysts see Avidity Biosciences Inc [RNA] gaining to $20. Time to buy?
Avidity Biosciences Inc [NASDAQ: RNA] gained 19.92% or 3.04 points to close at $18.30 with a heavy trading volume of 3963528 shares. The company report on February 29, 2024 at 12:00 PM that Avidity Biosciences Honors Rare Disease Day®. Avidity Biosciences, Inc. (Nasdaq: RNA), a
